APA (7th ed.) Citation

Ye, Y., Park, J., Kim, S., Cho, Y. S., Lee, S. Y., Lee, S. Y., . . . Park, H. (2024). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YH35324, a Novel Long-Acting High-Affinity IgETrap-Fc Fusion Protein, in Atopic Subjects with a Total IgE > 700 IU/mL. Journal of allergy and clinical immunology, 153(2), AB193. https://doi.org/10.1016/j.jaci.2023.11.622

Chicago Style (17th ed.) Citation

Ye, Young-Min, et al. "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YH35324, a Novel Long-Acting High-Affinity IgETrap-Fc Fusion Protein, in Atopic Subjects with a Total IgE > 700 IU/mL." Journal of Allergy and Clinical Immunology 153, no. 2 (2024): AB193. https://doi.org/10.1016/j.jaci.2023.11.622.

MLA (9th ed.) Citation

Ye, Young-Min, et al. "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YH35324, a Novel Long-Acting High-Affinity IgETrap-Fc Fusion Protein, in Atopic Subjects with a Total IgE > 700 IU/mL." Journal of Allergy and Clinical Immunology, vol. 153, no. 2, 2024, p. AB193, https://doi.org/10.1016/j.jaci.2023.11.622.